InvestorsHub Logo

dadofmarcmax

08/10/18 4:46 PM

#162435 RE: nidan7500 #162428

Plus 1 this post (I have none to give).

polarbear77

08/10/18 4:57 PM

#162436 RE: nidan7500 #162428

Great post Nidan, I appreciate your logical and fact based contributions here. I thought the conference call was excellent yesterday by the way.

LakeshoreLeo1953

08/14/18 10:53 AM

#162816 RE: nidan7500 #162428

THAT is the reason IMHO....

Hampel is enthusiastic about, if not totally endorsing, 2-73.

Hampel BELIEVES there are bodily functions which,
if properly targeted, can address individual disease.
I am wholeheartedly behind that hypothesis.

2-73 was shown to actually "enter" and affect S1.
What that may come to mean is WHY we have trials.

I am happy Anavex is seen as relevant in Hampel's world.
I look forward to the results from the process to
determine EFFICACY of 2-73 and its other molecules.